Bryostatin and Vincristine in B-Cell Malignancies

Summary

This phase I trial is studying the side effects and best dose of bryostatin-1 when given together with vincristine in treating patients with chronic lymphocytic leukemia, non-Hodgkin's lymphoma, or multiple myeloma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells

Timeline

Start

1998-05

Primary completion

2001-07

Completion

—

Drugs

Indications